| Literature DB >> 17110033 |
Brian T Hawkins1, Scott M Ocheltree, Kristi M Norwood, Richard D Egleton.
Abstract
Investigations of the blood-brain barrier (BBB) in diabetes have yielded contradictory results. It is possible that diabetes differentially affects paracellular and transcellular permeabilities via modulation of tight junction and transport proteins, respectively. Fluorescein (FL), a marker for paracellular permeability, is a substrate for the transport proteins organic anion transporter (OAT)-3 and multidrug resistance protein (MRP)-2 at the BBB. Furthermore, MRP-2-mediated efflux of FL can be upregulated by glucose. In this study, streptozotocin-induced diabetes led to decreased brain distribution of FL measured by in situ brain perfusion, consistent with activation of an efflux transport system for FL at the BBB. This change was paralleled by increased protein expression of MRP-2, but not OAT-3, in cerebral microvessels. These data indicate that diabetes may lead to changes in efflux transporters at the BBB and have implications for delivery of therapeutics to the central nervous system.Entities:
Mesh：
Substances：
Year: 2006 PMID： 17110033 PMCID： PMC1785293 DOI： 10.1016/j.neulet.2006.09.010
Source DB: PubMed Journal: Neurosci Lett ISSN： 0304-3940 Impact factor: 3.046